Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Estee Lauder

This article was originally published in The Rose Sheet

Executive Summary

Estee Lauder: Firm will merge sales and marketing operations of its Estee Lauder, Clinique and Aramis brands in Canada with the respective U.S. divisions in July in order to facilitate simultaneous product launches in the two regions, the company said. Sales and marketing for Prescriptives in Canada was integrated with the U.S. division in 1993. Estee Lauder began merging its Puerto Rico sales and marketing divisions with the corresponding U.S. divisions in April. Estee Lauder will continue to operate a manufacturing plant and financial offices in Canada and sales and training offices for the brands will still be headquartered in Toronto. The firm will also maintain offices for sales and training in Puerto Rico
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS001644

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel